English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 907549      在线人数 : 953
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版

    子类别

    期刊論文 [82/82]
    圖書 [5/6]
    會議論文/會議摘要 [14/17]

    邻近社群


    MARK LAWRENCE WAHLQVIST(2008-2012) [138/140]
    吳易謙 [54/55]
    吳秀英 [10/10]
    廖本揚 [39/39]
    廖玉潔 [63/65]
    張新儀 [245/268]
    李孟智 [51/54]
    李蘭 [28/28]
    林培生 [25/25]
    林煜軒 [47/47]
    林肇堂 [35/35]
    梁賡義 [15/15]
    江博煌 [72/78]
    溫啟邦(2001-2010) [177/188]
    潘文涵 [110/115]
    熊昭 [369/379]
    莊淑鈞 [43/44]
    莊紹源 [162/168]
    蔡慧如 [162/165]
    蔡憶文(1999-2010) [34/34]
    蕭金福 [188/197]
    藍祚運(2003-2011) [22/23]
    許志成 [385/393]
    邱亞文(2005-2013) [63/99]
    邱弘毅 [49/49]
    邱燕楓 [82/82]
    郭耿南(2003-2010) [89/105]
    鍾仁華 [85/86]
    陳主智 [61/61]
    陳慶餘(2006-2010) [70/70]
    陳美惠 [32/32]
    陳豐奇 [53/55]
    陳麗光 [106/106]
    黃國晉 [15/15]
    丘政民(2000-2004) [8/8]
    其他 [238/244]
    劉仁沛(1998-2002) [64/65]
    姚姿君(1999-2002) [3/3]
    戴東原(2003-2005) [21/22]
    李明亮(2003-2007) [6/6]
    林仲彥(1999-2005) [31/33]
    林錦瑜(2002-2003) [5/5]
    涂醒哲(2003-2004) [4/4]
    石曜堂(1999-2006) [20/24]
    蔡碧紋(2004-2006) [3/4]
    陳淑媛(2001-2004) [3/3]

    社群统计


    近3年内发表的文件:21(20.00%)
    含全文笔数:101(96.19%)

    文件下载次数统计
    下载大于0次:101(100.00%)
    下载大于100次:101(100.00%)
    全文下载总次数:45744(0.85%)

    最后更新时间: 2024-12-01 08:29

    上传排行

    数据加载中.....

    下载排行

    数据加载中.....

    RSS Feed RSS Feed
    跳至:
    或输入年份:
    由新到旧排序 由最旧的开始

    显示项目51-100 / 105. (共3页)
    << < 1 2 3 > >>
    每页显示[10|25|50]项目

    日期题名關聯
    2016-05-03 Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer Scientific Reports. 2016 May 3;6:Article number 25369.
    2016-04-21 The discrete random-effects model-assessing benefit and consistency of treatment effect Multiregional Clinical Trials for Simultaneous Global New Drug Development. 2016 Apr 21:245-258.
    2015-09-01 Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients International Journal of Cardiology. 2015 Sep 1;194:36-38.
    2015-05 A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer Annals of Oncology. 2015 May;26(5):943-949.
    2015-04 Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection Journal of Hepatology. 2015 Apr;62, Suppl. 2:S563.
    2014-06 Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study Hepatology. 2014 Jun; 59(6):2092-2100
    2014-04 The association of genetic polymorphisms in the kappa-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance Journal of Clinical Psychopharmacology. 2014 Apr;34(2):205-211.
    2014-04 Prevention of chemotherapy-induced hbv-related hepatitis flare in lymphoma patients with resolved hbv infection: Cost analysis Journal of Hepatology. 2014 Apr;60(1):S206-S207.
    2014-01 Establishing non-inferiority of a new treatment in a three-arm trial: Apply a step-down hierarchical model in a papulopustular acne study and an oral prophylactic antibiotics study International Journal of Statistics in Medical Research. 2014 Jan 31;3:11-20.
    2014-01 Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial Journal of Clinical Oncology. 2014 Jan;32(3 Suppl):Abstract number 267.
    2013-12 Pharmacogenomics study in a Taiwanese methadone maintenance cohort Journal of Food and Drug Analysis. 2013 Dec;21(4 Suppl.):S62-S68.
    2013-11 A 12-Year ecological study of hip fracture rates among older Taiwanese adults Calcified Tissue International. 2013 Nov;93(5):397-404.
    2013-11 Comparison of escitalopram and paroxetine in the treatment of major depressive disorder International Clinical Psychopharmacology. 2013 Nov;28(6):339-345.
    2013-09 Functional genetic polymorphisms in CYP2C19 Gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort OMICS :A Journal of Integrative Biology. 2013 Sep;17(10):519-526.
    2013-08-19 A consistency approach for evaluation of biosimilar products Journal of Biopharmaceutical Statistics. 2013 Aug 19;23(5):1054-1066.
    2013-07-23 Hepatitis C Virus infection influences the S-methadone metabolite plasma concentration PLoS ONE. 2013 Jul 23;8(7):Article number e69310.
    2013-07 CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions Pharmacogenomics. 2013 Jul;14(10):1191-1201.
    2013-06-27 Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance Journal of Biomedical Science. 2013 Jun 27;20(1):Article number 43.
    2013-05 KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number 4018.
    2013-04 Comparing multiple testing correction methods between two softwares for single nucleotide polymorphisms association analyses: Using OPRD1 and diastolic blood pressure in methadone maintenance patients as an example 2013 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB). 2013 Apr:154-159.
    2013-04 EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 2390.
    2013-02 OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: A cross sectional study Journal of Human Genetics. 2013 Feb;58(2):84-90.
    2012-10 Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients European Neuropsychopharmacology. 2012 Oct;22(10):695-703.
    2012-09-25 A pilot randomized controlled trial to improve geriatric frailty BMC Geriatrics. 2012 Sep 25;12(1):Article number 58.
    2012-09-04 Assessment of regional treatment effect in a multiregional clinical trial Journal of Biopharmaceutical Statistics. 2012 Sep 04;22(5):1019-1036.
    2012-09 Putative tumor metastasis-associated genes in human gastric cancer International Journal of Oncology. 2012 Sep;41(3):1068-1084.
    2012-09 Weighted evidence approach of bridging study Journal of Biopharmaceutical Statistics. 2012 Sep;22(5):952-965.
    2012-09 Design and analysis issues of multiregional clinical trials with different regional primary endpoints Journal of Biopharmaceutical Statistics. 2012 Sep;22(5):1051-1059.
    2012-07-26 Multiregional Clinical Trials Design and Analysis of Bridging Studies. 2012 Jul 26;Chapter 11:219-234.
    2012-07-26 A bayesian approach for evaluation of bridging studies Design and Analysis of Bridging Studies. 2012 Jul 26;Chapter 6:89-104.
    2012-07-26 Two-stage designs of bridging studies Design and Analysis of Bridging Studies. 2012 Jul 26;Chapter 2:17-32.
    2012-07 Establishing consistency across all regions in a multi-regional clinical trial Pharmaceutical Statistics. 2012 Jul;11(4):295-299.
    2012-06 UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients Pharmacogenomics. 2012 Jun;13(8):879-888.
    2012-03 CYP1A2 genetic polymorphisms associated with antidepressant escitalopram metabolism and adverse reactions at early stage Clinical Pharmacology and Therapeutics. 2012 Mar;91(Suppl. 1):S62.
    2011-10 Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients Pharmacogenomics. 2011 Oct;12(10):1397-1406.
    2011-09-23 A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou European Journal of Cancer. 2011 Sep 23;47:S547-S548.
    2011-08 CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer Journal of Clinical Psychopharmacology. 2011 Aug;31(4):463-469.
    2011-07 A consistency approach to evaluation of bridging studies and multiregional trials Statistics in Medicine. 2011 Jul;30(17):2171-2186.
    2011-05 Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine Drug Metabolism Reviews. 2011 May;43(Suppl.1):71.
    2011-05 The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction Drug Metabolism Reviews. 2011 May;43(Suppl.1):26.
    2011-05 Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine Drug Metabolism Reviews. 2011 May;43(Suppl.1):25-26.
    2011-05 Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients Biological Psychiatry. 2011 May;69(9 Suppl.1):229S-230S.
    2011-04 ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment Pharmacogenetics and Genomics. 2011 Apr;21(4):163-170.
    2010-11 CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine Pharmacogenomics. 2010 Nov;11(11):1535-1543.
    2010-07 Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials - Asian perspective Pharmaceutical Statistics. 2010 Jul;9(3):201-206.
    2010-07 Sample size determination for a specific region in a multiregional trial Journal of Biopharmaceutical Statistics. 2010 Jul;20(4):870-885.
    2010-05 Validation of the Chinese-Canadian study of health and aging clinical frailty scale (CSHA-CFS) telephone version Archives of Gerontology and Geriatrics. 2010 May-Jun;50(3):e74-e80.
    2009 Statistical validation of traditional Chinese diagnostic procedures Drug Information Journal. 2009;43(1):83-95.
    2009 Translation in clinical technology-traditional Chinese medicine Translational Medicine: Strategies and Statistical Methods. 2009:205-218.
    2008-12 Translation in different diagnostic procedures—traditional Chinese medicine and western medicine Journal of the Formosan Medical Association. 2008 Dec;107(12, Suppl.1):74-85.

    显示项目51-100 / 105. (共3页)
    << < 1 2 3 > >>
    每页显示[10|25|50]项目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈